{"componentChunkName":"component---src-templates-study-details-page-js","path":"/en/study/CCR102709","result":{"data":{"studyNotFoundJson":{"title":"Study not found","content":{"childMarkdownRemark":{"html":"<p>If you entered a web address please check it was correct.</p>\n<p>You can also try <a href=\"/en/studies\">Search Page</a> to find the study you are looking for.</p>"}}},"trialDetailsJson":{"title":"Details Page","returnSearch":"Back to search results","description":"Study Description","identifier":"ViiV Study ID","clinicalID":"Clinicaltrials.gov Identifier","EudraCtID":"EudraCT Number","resultsAvailable":"Has Results Available Below","docAvailable":"Has Results Document Available","studyOverview":"Study Overview","overviewSection":{"conditionsDisplay":"Medical Conditions","product":"Product","collaborators":"Collaborators","dates":"Date","studyType":"Type","phase":"Phase","gender":"Gender","age":"Age","acceptVolunteers":"Accepts Healthy Volunteers"},"studyDocuments":"Study Documents","noDocuments":"No documents available","studyDocumentsAdditionalText":"If you wish to request for Full Study Report, please contact - ","studyDocumentsAdditionalEmail":"GSKClinicalSupportHD@gsk.com","isReleased":{"firstPart":"This study has Protocol and Result summary on ClinicalTrial.gov. Click","secondPart":"to learn more.","linkText":"here"},"mapLocations":"Locations","centralContact":"Central Contact","centralPhone":"Central Contact Phone","centralEmail":"Central Contact Email","mapSection":{"site":"GSK Investigational Site","condition":"Condition","id":"Study ID","city":"City","state":"State","zip":"Zip","country":"Country"},"studyDesign":"Study Design","designSection":{"purpose":"Primary Purpose","allocation":"Allocation","study_design":"Study Design","study_classification":"Study Classification","masking":"Masking","masked_subject":"Masked Subject","masked_caregiver":"Masked Caregiver","masked_investigator":"Masked Investigator","masked_assessor":"Masked Assessor","primary_outcomes":"Primary Outcomes","secondary_outcomes":"Secondary Outcomes","arms":"Arms","interventions":"Interventions","keyword":"Keyword","inclusionTitle":"Inclusion Criteria","exclusionTitle":"Exclusion Criteria","criteriaText":"Inclusion/Exclusion Criteria","criteria_button":"Click to view inclusion/exclusion criteria","enrollment":"Enrollment","clinicalPublications":"Clinical Publications"},"popoversText":{"studyId":{"childMarkdownRemark":{"html":"<p>A unique number for a study given by ViiV.</p>"}},"ctGov":{"childMarkdownRemark":{"html":"<p>This number identifies the study on the US clinicaltrials.gov register. Click this link to go to the entry for this study on Clinicaltrials.gov where you will be able to see protocol and results summaries where available.</p>"}},"eudraCT":{"childMarkdownRemark":{"html":"<p>This number identifies the study on the EU clinicaltrials.eu register. Click this link to go to the entry for this study on clinicaltrials.eu where you will be able to see protocol and results summaries where available.</p>"}}}},"site":{"siteMetadata":{"siteUrl":"https://www.viiv-studyregister.com"}},"studyDetails":{"nct_number":"NCT00197145","ctis_id":"","HasResults":"true","IpdAccessCriteria":"","IpdDescription":"","IpdInfoTypeAnalyticCode":"","IpdInfoTypeIcf":"","IpdInfoTypeCsr":"","IpdInfoTypeProtocol":"","IpdInfoTypeSap":"","IpdTimeFrame":"","IpdUrl":"http://","IsFlexibleTrial":false,"IsReleasedToCtGov":"true","MaskingInfo":{"masked_assessor":"false","masked_caregiver":"false","masked_investigator":"false","masked_subject":"false","masking_description":"","no_masking":"false"},"PatientLevelData":"false","SharingIpd":"None","acronym":"","allocation":"Randomized","arm_groups":[{"arm_group_label":"GW873140","arm_group_description":"","arm_type":"Experimental"}],"assignment":"Parallel Assignment","brief_summary":"The purpose of this study is to evaluate the safety and efficacy of the CCR5 antagonist GW873140 or placebo in combination with an optimized background regimen in treatment-experienced HIV-infected subjects with R5-tropic virus","brief_summary_OneLinkTx":"","brief_title_OneLinkTx":"","brief_title":"Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects","conditions":[{"DisplayValue":"Human Immunodeficiency Virus (HIV)","DisplayValue_OneLinkTx":"","InternalValue":"CON_HIV","LookupValue":"Infection, Human Immunodeficiency Virus I","LookupValue_OneLinkTx":""}],"created_date":"09/15/2018 17:27:03","criteria":"Inclusion Criteria: - HIV-infected. - Screening viral load at least 5000copies/mL. - R5-tropic only virus at screening. - Total prior antiretroviral experience of at least 3 months and documented resistance to at least one drug in each of the following classes: nucleoside reverse transcriptase inhibitors (NRTI), non-nucleoside reverse transcriptase inhibitors (NNRTI), and protease inhibitors (PI). - Stable antiretroviral regimen (or no antiretroviral treatment) for at least 4 weeks before screening. - Able to receive a ritonavir-boosted protease inhibitor during treatment studies. - Women of childbearing potential must use specific forms of contraception. Exclusion criteria: - Acute laboratory abnormalities. - History of pancreatitis or hepatitis, hepatitis B or hepatitis C coinfection, or any chronic liver disease. Screening liver function tests will be used to determine eligibility. - R5/X4-tropic, X4-tropic only, or non-phenotypeable virus at screening. - Changes to antiretroviral therapy from 4 weeks prior to screening until Day 1 of treatment study. - Pregnancy or breastfeeding women. - Recent participation in an experimental drug trial. - Prior use of a CCR5 or CXCR4 antagonist. - Significant ECG abnormalities or significant history of active pancreatitis, hepatitis, opportunistic infections, malabsorption disorders, cancer, or severe illness. - Current use of certain medications may exclude participation in this study. - Additional qualifying criteria and laboratory test requirements to be assessed by study physician.","detailed_description":"","display_gender":"Both","display_gender_internal":"GENDER_ALL","display_phase":"Phase 3","display_phase_internal":"PHASE_3","display_status":"Other","display_status_internal":"RECSTATUS_OTHER","endpoint":"","enrollment":"24","exclusion":"","gender":"All","gender_based":"","gender_description":"","healthy_volunteers":"No","id":"774120db-99f8-58a2-9eb3-3bc53dd2fcc0","internal":{"content":null,"contentDigest":"6c8ca59f2cbddfc4fa679ec07f9a40ce","description":null,"fieldOwners":null,"mediaType":null,"ignoreType":null,"owner":"default-site-plugin","type":"studyDetails"},"inclusion":"Inclusion Criteria: - HIV-infected. - Screening viral load at least 5000copies/mL. - R5-tropic only virus at screening. - Total prior antiretroviral experience of at least 3 months and documented resistance to at least one drug in each of the following classes: nucleoside reverse transcriptase inhibitors (NRTI), non-nucleoside reverse transcriptase inhibitors (NNRTI), and protease inhibitors (PI). - Stable antiretroviral regimen (or no antiretroviral treatment) for at least 4 weeks before screening. - Able to receive a ritonavir-boosted protease inhibitor during treatment studies. - Women of childbearing potential must use specific forms of contraception. Exclusion criteria: - Acute laboratory abnormalities. - History of pancreatitis or hepatitis, hepatitis B or hepatitis C coinfection, or any chronic liver disease. Screening liver function tests will be used to determine eligibility. - R5/X4-tropic, X4-tropic only, or non-phenotypeable virus at screening. - Changes to antiretroviral therapy from 4 weeks prior to screening until Day 1 of treatment study. - Pregnancy or breastfeeding women. - Recent participation in an experimental drug trial. - Prior use of a CCR5 or CXCR4 antagonist. - Significant ECG abnormalities or significant history of active pancreatitis, hepatitis, opportunistic infections, malabsorption disorders, cancer, or severe illness. - Current use of certain medications may exclude participation in this study. - Additional qualifying criteria and laboratory test requirements to be assessed by study physician.","interventions":[{"arm_group_label":"GW873140","intervention_description":"400 mg twice daily","intervention_name":"GW873140","intervention_type":"Drug"}],"interventional_subtype":"Treatment","is_fda_regulated":true,"is_high_value":false,"is_ind_study":true,"keywords":["HIV-1 GW873140 CCR5 antagonist experienced"],"last_follow_up_date":"09/11/2007 00:00:00","links":[],"locations":[{"City":"Toronto","Latitude":"43.6622852","CountryDisplay":"Canada","Longitude":"-79.3790251","Name":"GSK Investigational Site","StateDisplay":"Ontario","PostalCode":"M5B 1L6","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Tarzana","Latitude":"34.1662848","CountryDisplay":"United States","Longitude":"-118.5447787","Name":"GSK Investigational Site","StateDisplay":"California","PostalCode":"91356","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Tarzana","Latitude":"34.1662848","CountryDisplay":"United States","Longitude":"-118.5447787","Name":"GSK Investigational Site","StateDisplay":"California","PostalCode":"91356","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Birmingham","Latitude":"33.5075555","CountryDisplay":"United States","Longitude":"-86.8093239","Name":"GSK Investigational Site","StateDisplay":"Alabama","PostalCode":"35294","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Norwalk","Latitude":"41.1339818","CountryDisplay":"United States","Longitude":"-73.4062342","Name":"GSK Investigational Site","StateDisplay":"Connecticut","PostalCode":"06851","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Oakland","Latitude":"37.8321173","CountryDisplay":"United States","Longitude":"-122.2625529","Name":"GSK Investigational Site","StateDisplay":"California","PostalCode":"94609","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Boston","Latitude":"42.3476181","CountryDisplay":"United States","Longitude":"-71.1002881","Name":"GSK Investigational Site","StateDisplay":"Massachusetts","PostalCode":"02215","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Newark","Latitude":"40.7350747","CountryDisplay":"United States","Longitude":"-74.1739057","Name":"GSK Investigational Site","StateDisplay":"New Jersey","PostalCode":"07102","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Columbia","Latitude":"34.0258687","CountryDisplay":"United States","Longitude":"-80.9594751","Name":"GSK Investigational Site","StateDisplay":"South Carolina","PostalCode":"29206-4713","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"East Orange","Latitude":"40.7564795","CountryDisplay":"United States","Longitude":"-74.2208673","Name":"GSK Investigational Site","StateDisplay":"New Jersey","PostalCode":"07018","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Washington","Latitude":"38.9042365","CountryDisplay":"United States","Longitude":"-77.0521289","Name":"GSK Investigational Site","StateDisplay":"District of Columbia","PostalCode":"20037","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Lynchburg","Latitude":"37.4137536","CountryDisplay":"United States","Longitude":"-79.1422464","Name":"GSK Investigational Site","StateDisplay":"Virginia","PostalCode":"24501","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Glastonbury","Latitude":"41.7056381","CountryDisplay":"United States","Longitude":"-72.5559746","Name":"GSK Investigational Site","StateDisplay":"Connecticut","PostalCode":"06033","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Miami","Latitude":"25.7870967","CountryDisplay":"United States","Longitude":"-80.2042436","Name":"GSK Investigational Site","StateDisplay":"Florida","PostalCode":"33136","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Fort Myers","Latitude":"26.6235485","CountryDisplay":"United States","Longitude":"-81.8770671","Name":"GSK Investigational Site","StateDisplay":"Florida","PostalCode":"33901","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Hampton","Latitude":"37.0538822","CountryDisplay":"United States","Longitude":"-76.3984537","Name":"GSK Investigational Site","StateDisplay":"Virginia","PostalCode":"23666","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Minneapolis","Latitude":"44.9605503","CountryDisplay":"United States","Longitude":"-93.2616717","Name":"GSK Investigational Site","StateDisplay":"Minnesota","PostalCode":"55404","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Baltimore","Latitude":"39.2963369","CountryDisplay":"United States","Longitude":"-76.6210539","Name":"GSK Investigational Site","StateDisplay":"Maryland","PostalCode":"21201","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Mount Vernon","Latitude":"40.9087956","CountryDisplay":"United States","Longitude":"-73.8330844","Name":"GSK Investigational Site","StateDisplay":"New York","PostalCode":"10550","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Dallas","Latitude":"32.7962048","CountryDisplay":"United States","Longitude":"-96.7694752","Name":"GSK Investigational Site","StateDisplay":"Texas","PostalCode":"75246","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Hillsborough","Latitude":"40.5106594","CountryDisplay":"United States","Longitude":"-74.6472522","Name":"GSK Investigational Site","StateDisplay":"New Jersey","PostalCode":"08844","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Portland","Latitude":"45.5266975","CountryDisplay":"United States","Longitude":"-122.6880503","Name":"GSK Investigational Site","StateDisplay":"Oregon","PostalCode":"97209","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Oakland Park","Latitude":"26.180392","CountryDisplay":"United States","Longitude":"-80.1372757","Name":"GSK Investigational Site","StateDisplay":"Florida","PostalCode":"33334","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Orlando","Latitude":"28.5747416","CountryDisplay":"United States","Longitude":"-81.3949264","Name":"GSK Investigational Site","StateDisplay":"Florida","PostalCode":"32804","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Key West","Latitude":"24.5550593","CountryDisplay":"United States","Longitude":"-81.7799871","Name":"GSK Investigational Site","StateDisplay":"Florida","PostalCode":"33040","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Fort Lauderdale","Latitude":"26.1640451","CountryDisplay":"United States","Longitude":"-80.1121493","Name":"GSK Investigational Site","StateDisplay":"Florida","PostalCode":"33306","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"San Juan","Latitude":"18.45","CountryDisplay":"Puerto Rico","Longitude":"-66.0699999","Name":"GSK Investigational Site","StateDisplay":"Puerto Rico","PostalCode":"00910","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Ft. Lauderdale","Latitude":"26.1640451","CountryDisplay":"United States","Longitude":"-80.1121493","Name":"GSK Investigational Site","StateDisplay":"Florida","PostalCode":"33306","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Akron","Latitude":"41.0801473","CountryDisplay":"United States","Longitude":"-81.5020328","Name":"GSK Investigational Site","StateDisplay":"Ohio","PostalCode":"44304","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Los Angeles","Latitude":"34.0931603","CountryDisplay":"United States","Longitude":"-118.3783347","Name":"GSK Investigational Site","StateDisplay":"California","PostalCode":"90069","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Fountain Valley","Latitude":"33.7168761","CountryDisplay":"United States","Longitude":"-117.9600466","Name":"GSK Investigational Site","StateDisplay":"California","PostalCode":"92708","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"St. Louis","Latitude":"38.647459","CountryDisplay":"United States","Longitude":"-90.25731","Name":"GSK Investigational Site","StateDisplay":"Missouri","PostalCode":"63108","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Ponce","Latitude":"18.1311468","CountryDisplay":"Puerto Rico","Longitude":"-66.6395219","Name":"GSK Investigational Site","StateDisplay":"Puerto Rico","PostalCode":"00731","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Laguna Beach","Latitude":"33.5563145","CountryDisplay":"United States","Longitude":"-117.77252","Name":"GSK Investigational Site","StateDisplay":"California","PostalCode":"92651","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Fort Lauderdale","Latitude":"26.1897731","CountryDisplay":"United States","Longitude":"-80.1037721","Name":"GSK Investigational Site","StateDisplay":"Florida","PostalCode":"33308","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Wichita","Latitude":"37.7040524","CountryDisplay":"United States","Longitude":"-97.3138554","Name":"GSK Investigational Site","StateDisplay":"Kansas","PostalCode":"67214","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Chicago","Latitude":"41.9403795","CountryDisplay":"United States","Longitude":"-87.6531805","Name":"GSK Investigational Site","StateDisplay":"Illinois","PostalCode":"60657","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Beverly Hills","Latitude":"34.1030032","CountryDisplay":"United States","Longitude":"-118.4104684","Name":"GSK Investigational Site","StateDisplay":"California","PostalCode":"90210","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Annandale","Latitude":"38.8327423","CountryDisplay":"United States","Longitude":"-77.2060241","Name":"GSK Investigational Site","StateDisplay":"Virginia","PostalCode":"22003","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Las Vegas","Latitude":"36.1462673","CountryDisplay":"United States","Longitude":"-115.1829873","Name":"GSK Investigational Site","StateDisplay":"Nevada","PostalCode":"89102","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Atlanta","Latitude":"33.776402","CountryDisplay":"United States","Longitude":"-84.38926","Name":"GSK Investigational Site","StateDisplay":"Georgia","PostalCode":"30308/30309","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Plantation","Latitude":"26.1218038","CountryDisplay":"United States","Longitude":"-80.2209773","Name":"GSK Investigational Site","StateDisplay":"Florida","PostalCode":"33317","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Long Beach","Latitude":"33.7844997","CountryDisplay":"United States","Longitude":"-118.1971031","Name":"GSK Investigational Site","StateDisplay":"California","PostalCode":"90813","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"San Francisco","Latitude":"37.7561438","CountryDisplay":"United States","Longitude":"-122.4325682","Name":"GSK Investigational Site","StateDisplay":"California","PostalCode":"94114","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Houston","Latitude":"29.740582","CountryDisplay":"United States","Longitude":"-95.4515725","Name":"GSK Investigational Site","StateDisplay":"Texas","PostalCode":"77027","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Charlotte","Latitude":"35.1811188","CountryDisplay":"United States","Longitude":"-80.8488498","Name":"GSK Investigational Site","StateDisplay":"North Carolina","PostalCode":"28209","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Portland","Latitude":"45.4618086","CountryDisplay":"United States","Longitude":"-122.7181903","Name":"GSK Investigational Site","StateDisplay":"Oregon","PostalCode":"97219","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Atlanta","Latitude":"33.8676889","CountryDisplay":"United States","Longitude":"-84.4645184","Name":"GSK Investigational Site","StateDisplay":"Georgia","PostalCode":"30339","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Portland","Latitude":"43.6611308","CountryDisplay":"United States","Longitude":"-70.2989334","Name":"GSK Investigational Site","StateDisplay":"Maine","PostalCode":"04102","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Austin","Latitude":"30.2962208","CountryDisplay":"United States","Longitude":"-97.8299383","Name":"GSK Investigational Site","StateDisplay":"Texas","PostalCode":"78746","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Spokane","Latitude":"47.6457534","CountryDisplay":"United States","Longitude":"-117.4253653","Name":"GSK Investigational Site","StateDisplay":"Washington","PostalCode":"99204","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Los Angeles","Latitude":"34.1147313","CountryDisplay":"United States","Longitude":"-118.3637264","Name":"GSK Investigational Site","StateDisplay":"California","PostalCode":"90046","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Chicago","Latitude":"41.9577761","CountryDisplay":"United States","Longitude":"-87.6556468","Name":"GSK Investigational Site","StateDisplay":"Illinois","PostalCode":"60613","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"New Orleans","Latitude":"29.9510658","CountryDisplay":"United States","Longitude":"-90.0715323","Name":"GSK Investigational Site","StateDisplay":"Louisiana","PostalCode":"70127-0800","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Washington","Latitude":"38.9191485","CountryDisplay":"United States","Longitude":"-77.0362967","Name":"GSK Investigational Site","StateDisplay":"District of Columbia","PostalCode":"20009","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Decatur","Latitude":"33.8092255","CountryDisplay":"United States","Longitude":"-84.2805478","Name":"GSK Investigational Site","StateDisplay":"Georgia","PostalCode":"30033","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Oakland","Latitude":"37.8321173","CountryDisplay":"United States","Longitude":"-122.2625529","Name":"GSK Investigational Site","StateDisplay":"California","PostalCode":"94609","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"New York","Latitude":"40.7366138","CountryDisplay":"United States","Longitude":"-74.0094471","Name":"GSK Investigational Site","StateDisplay":"New York","PostalCode":"10014","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"}],"masking":"","maximum_age_raw":"N/A","maximum_age":"N/A","minimum_age":"18","minimum_age_raw":"18 years","modified_date":"10/01/2018 23:01:39","number_of_arms":"1","observational_design":{"biospecimen_description":"","biospecimen_retention":"","number_of_groups":"","observational_study_design":"","patient_registry":"","target_duration_quantity":"","target_duration_units":"","timing":""},"official_title":"A Phase III, randomized, double-blind, placebo-controlled, multicenter, parallel group study to compare the efficacy and safety of GW873140 400mg BID in combination with a ritonavir-containing optimized background therapy (OBT) regimen versus placebo plus OBT over 48 weeks.","org_study_id":"CCR102709","overall_contact":{"email":"GSKClinicalSupportHD@gsk.com","last_name":"Call Center","phone":"877-379-3718"},"overall_status":"Terminated","oversight_info":{"exported_from_us":"","fda_regulated_device":"","fda_regulated_drug":"","ped_postmarket_surv":"","has_dmc":null,"post_prior_to_approval":"","regulatory_authorities":[""]},"phase":"3","primary_compl_date":"09/11/2007 00:00:00","primary_outcomes":[],"product_name":"","product_name_OneLinkTx":"","secondary_ids":[],"secondary_outcomes":[{"outcome_description":null,"outcome_measure":null,"outcome_time_frame":null,"outcome_safety_issue":null}],"sponsors":{"investigator_affiliation":"","investigator_username":"","lead_sponsor":"ViiV Healthcare","collaborators":["GSK"]},"start_date":"07/21/2005 00:00:00","study_type":"Interventional","therapeutic_area":"Infectious Diseases","citations":[],"is_section_801":null}},"pageContext":{"studyId":"CCR102709"}},"staticQueryHashes":["162689979","3332233851","3729204765","3769354840","399703114"]}